5S Ribosomal RNA Is an Essential Component of a Nascent Ribosomal Precursor Complex that Regulates the Hdm2-p53 Checkpoint

Cell Reports

Volumn 4, Issue 1, 2013, Pages 87-98

  Donati, Giulio ^a,b   Peddigari, Suresh ^b   Mercer, Carol A ^b   Thomas, George ^a,b  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA DIRECTED RNA POLYMERASE III; PROTEIN MDM2; PROTEIN P53; RIBOSOME PROTEIN; RIBOSOME PROTEIN L11; RIBOSOME PROTEIN L5; RIBOSOME RNA; RNA 5S; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; BIOGENESIS; CELL CYCLE PROGRESSION; CELL LEVEL; COMPLEX FORMATION; CONTROLLED STUDY; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; RNA SYNTHESIS;

CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; HUMANS; PROTO-ONCOGENE PROTEINS C-MDM2; RIBOSOMAL PROTEINS; RNA PRECURSORS; RNA, RIBOSOMAL, 5S; TRANSCRIPTION FACTOR TFIIIA; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84892443134     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.05.045     Document Type: Article

References (56)

1. Amsterdam A., Sadler K.C., Lai K., Farrington S., Bronson R.T., Lees J.A., Hopkins N. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol. 2004, 2:E139.
2. Barak Y., Juven T., Haffner R., Oren M. mdm2 expression is induced by wild type p53 activity. EMBO J. 1993, 12:461-468.
3. Barna M., Pusic A., Zollo O., Costa M., Kondrashov N., Rego E., Rao P.H., Ruggero D. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 2008, 456:971-975.
4. Bhat K.P., Itahana K., Jin A., Zhang Y. Essential role of ribosomal protein L11 in mediating growth inhibition-induced p53 activation. EMBO J. 2004, 23:2402-2412.
5. Bond G.L., Hu W., Bond E.E., Robins H., Lutzker S.G., Arva N.C., Bargonetti J., Bartel F., Taubert H., Wuerl P., et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 2004, 119:591-602.
6. Bursać S., Brdovčak M.C., Pfannkuchen M., Orsolić I., Golomb L., Zhu Y., Katz C., Daftuar L., Grabušić K., Vukelić I., et al. Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stress. Proc. Natl. Acad. Sci. USA 2012, 109:20467-20472.
7. Bywater M.J., Poortinga G., Sanij E., Hein N., Peck A., Cullinane C., Wall M., Cluse L., Drygin D., Anderes K., et al. Inhibition of RNA polymerase I asa therapeutic strategy to promote cancer-specific activation of p53. Cancer Cell 2012, 22:51-65.
8. Challagundla K.B., Sun X.X., Zhang X., DeVine T., Zhang Q., Sears R.C., Dai M.S. Ribosomal protein L11 recruits miR-24/miRISC to repress c-Myc expression in response to ribosomal stress. Mol. Cell. Biol. 2011, 31:4007-4021.
9. Ciganda M., Williams N. Eukaryotic 5S rRNA biogenesis. Wiley Interdiscip. Rev. RNA 2011, 2:523-533.
10. Dai M.S., Lu H. Inhibition of MDM2-mediated p53 ubiquitination and degradation by ribosomal protein L5. J.Biol. Chem. 2004, 279:44475-44482.
11. Dai M.S., Arnold H., Sun X.X., Sears R., Lu H. Inhibition of c-Myc activity by ribosomal protein L11. EMBO J. 2007, 26:3332-3345.
12. Dechampesme A.M., Koroleva O., Leger-Silvestre I., Gas N., Camier S. Assembly of 5S ribosomal RNA is required at a specific step of the pre-rRNA processing pathway. J.Cell Biol. 1999, 145:1369-1380.
13. Donati G., Bertoni S., Brighenti E., Vici M., Treré D., Volarevic S., Montanaro L., Derenzini M. The balance between rRNA and ribosomal protein synthesis up- and downregulates the tumour suppressor p53 in mammalian cells. Oncogene 2011, 30:3274-3288.
14. Draptchinskaia N., Gustavsson P., Andersson B., Pettersson M., Willig T.N., Dianzani I., Ball S., Tchernia G., Klar J., Matsson H., et al. The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat. Genet. 1999, 21:169-175.
15. Engelke D.R., Ng S.Y., Shastry B.S., Roeder R.G. Specific interaction of a purified transcription factor with an internal control region of 5S RNA genes. Cell 1980, 19:717-728.
16. Fumagalli S., Thomas G. The role of p53 in ribosomopathies. Semin. Hematol. 2011, 48:97-105.
17. Fumagalli S., Di Cara A., Neb-Gulati A., Natt F., Schwemberger S., Hall J., Babcock G.F., Bernardi R., Pandolfi P.P., Thomas G. Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat. Cell Biol. 2009, 11:501-508.
18. Fumagalli S., Ivanenkov V.V., Teng T., Thomas G. Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. Genes Dev. 2012, 26:1028-1040.
19. Gambe A.E., Matsunaga S., Takata H., Ono-Maniwa R., Baba A., Uchiyama S., Fukui K. A nucleolar protein RRS1 contributes to chromosome congression. FEBS Lett. 2009, 583:1951-1956.
20. Gazda H.T., Sheen M.R., Vlachos A., Choesmel V., O'Donohue M.F., Schneider H., Darras N., Hasman C., Sieff C.A., Newburger P.E., et al. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am. J. Hum. Genet. 2008, 83:769-780.
21. Gottlieb E., Steitz J.A. Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III. EMBO J. 1989, 8:851-861.
22. Hirano Y., Ishii K., Kumeta M., Furukawa K., Takeyasu K., Horigome T. Proteomic and targeted analytical identification of BXDC1 and EBNA1BP2 as dynamic scaffold proteins in the nucleolus. Genes Cells 2009, 14:155-166.
23. Ho J.S., Ma W., Mao D.Y., Benchimol S. p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest. Mol.Cell. Biol. 2005, 25:7423-7431.
24. Horn H.F., Vousden K.H. Coping with stress: multiple ways to activate p53. Oncogene 2007, 26:1306-1316.
25. Horn H.F., Vousden K.H. Cooperation between the ribosomal proteins L5 and L11 in the p53 pathway. Oncogene 2008, 27:5774-5784.
26. Jones N.C., Lynn M.L., Gaudenz K., Sakai D., Aoto K., Rey J.P., Glynn E.F., Ellington L., Du C., Dixon J., et al. Prevention of the neurocristopathy Treacher Collins syndrome through inhibition of p53 function. Nat. Med. 2008, 14:125-133.
27. Knight E., Darnell J.E. Distribution of 5s RNA in HeLa cells. J.Mol. Biol. 1967, 28:491-502.
28. Li M., Gu W. A critical role for noncoding 5S rRNA in regulating Mdmx stability. Mol. Cell 2011, 43:1023-1032.
29. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
30. Lohrum M.A., Ludwig R.L., Kubbutat M.H., Hanlon M., Vousden K.H. Regulation of HDM2 activity by the ribosomal protein L11. Cancer Cell 2003, 3:577-587.
31. Macias E., Jin A., Deisenroth C., Bhat K., Mao H., Lindström M.S., Zhang Y. An ARF-independent c-MYC-activated tumor suppression pathway mediated by ribosomal protein-Mdm2 Interaction. Cancer Cell 2010, 18:231-243.
32. MacInnes A.W., Amsterdam A., Whittaker C.A., Hopkins N., Lees J.A. Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations. Proc. Natl. Acad. Sci. USA 2008, 105:10408-10413.
33. Marechal V., Elenbaas B., Piette J., Nicolas J.C., Levine A.J. The ribosomal L5 protein is associated with mdm-2 and mdm-2-p53 complexes. Mol. Cell. Biol. 1994, 14:7414-7420.
34. Marine J.C., Jochemsen A.G. Mdmx and Mdm2: brothers in arms?. Cell Cycle 2004, 3:900-904.
35. McGowan K.A., Pang W.W., Bhardwaj R., Perez M.G., Pluvinage J.V., Glader B.E., Malek R., Mendrysa S.M., Weissman I.L., Park C.Y., Barsh G.S. Reduced ribosomal protein gene dosage and p53 activation in low-risk myelodysplastic syndrome. Blood 2011, 118:3622-3633.
36. Montes de Oca Luna R., Wagner D.S., Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 1995, 378:203-206.
37. Panić L., Tamarut S., Sticker-Jantscheff M., Barkić M., Solter D., Uzelac M., Grabusić K., Volarević S. Ribosomal protein S6 gene haploinsufficiency is associated with activation of a p53-dependent checkpoint during gastrulation. Mol. Cell. Biol. 2006, 26:8880-8891.
38. Perry R.P. Selective effects of actinomycin D on the intracellular distribution of RNA synthesis in tissue culture cells. Exp. Cell Res. 1963, 29:400-406.
39. Phillips W.F., McConkey E.H. Relative stoichiometry in ribosomal proteins in HeLa cell nucleoli. J.Biol. Chem. 1976, 251:2876-2881.
40. Rubbi C.P., Milner J. Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J. 2003, 22:6068-6077.
41. Ruggero D., Pandolfi P.P. Does the ribosome translate cancer?. Nat. Rev. Cancer 2003, 3:179-192.
42. Sachdeva M., Zhu S., Wu F., Wu H., Walia V., Kumar S., Elble R., Watabe K., Mo Y.Y. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl. Acad. Sci. USA 2009, 106:3207-3212.
43. Sasaki M., Kawahara K., Nishio M., Mimori K., Kogo R., Hamada K., Itoh B., Wang J., Komatsu Y., Yang Y.R., et al. Regulation of the MDM2-P53 pathway and tumor growth by PICT1 via nucleolar RPL11. Nat. Med. 2011, 17:944-951.
44. Shastry B.S., Honda B.M., Roeder R.G. Altered levels of a 5S gene-specific transcription factor (TFIIIA) during oogenesis and embryonic development of Xenopus laevis. J.Biol. Chem. 1984, 259:11373-11382.
45. Shor B., Wu J., Shakey Q., Toral-Barza L., Shi C., Follettie M., Yu K. Requirement of the mTOR kinase for the regulation of Maf1 phosphorylation and control of RNA polymerase III-dependent transcription in cancer cells. J.Biol. Chem. 2010, 285:15380-15392.
46. Steitz J.A., Berg C., Hendrick J.P., La Branche-Chabot H., Metspalu A., Rinke J., Yario T. A 5S rRNA/L5 complex is a precursor to ribosome assembly in mammalian cells. J.Cell Biol. 1988, 106:545-556.
47. Stewart M.J., Denell R. Mutations in the Drosophila gene encoding ribosomal protein S6 cause tissue overgrowth. Mol. Cell. Biol. 1993, 13:2524-2535.
48. Thomson E., Tollervey D. Nop53p is required for late 60S ribosome subunit maturation and nuclear export in yeast. RNA 2005, 11:1215-1224.
49. Toledo F., Wahl G.M. Regulating the p53 pathway: invitro hypotheses, invivo veritas. Nat. Rev. Cancer 2006, 6:909-923.
50. van Riggelen J., Yetil A., Felsher D.W. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat. Rev. Cancer 2010, 10:301-309.
51. Vlachos A., Rosenberg P.S., Atsidaftos E., Alter B.P., Lipton J.M. Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood 2012, 119:3815-3819.
52. Wilkinson D.S., Pitot H.C. Inhibition of ribosomal ribonucleic acid maturation in Novikoff hepatoma cells by 5-fluorouracil and 5-fluorouridine. J.Biol. Chem. 1973, 248:63-68.
53. Winter A.G., Sourvinos G., Allison S.J., Tosh K., Scott P.H., Spandidos D.A., White R.J. RNA polymerase III transcription factor TFIIIC2 is overexpressed in ovarian tumors. Proc. Natl. Acad. Sci. USA 2000, 97:12619-12624.
54. Wu X., Bayle J.H., Olson D., Levine A.J. The p53-mdm-2 autoregulatory feedback loop. Genes Dev. 1993, 7(7A):1126-1132.
55. Zhang J., Harnpicharnchai P., Jakovljevic J., Tang L., Guo Y., Oeffinger M., Rout M.P., Hiley S.L., Hughes T., Woolford J.L. Assembly factors Rpf2 and Rrs1 recruit 5S rRNA and ribosomal proteins rpL5 and rpL11 into nascent ribosomes. Genes Dev. 2007, 21:2580-2592.
56. Zhang Y., Lu H. Signaling to p53: ribosomal proteins find their way. Cancer Cell 2009, 16:369-377.